[
    [
        {
            "time": "",
            "original_text": "每日医药简讯：多地医用耗材带量采购陆续推进、赛诺医疗二代颅内球囊扩张导管获批上市",
            "features": {
                "keywords": [
                    "医用耗材",
                    "带量采购",
                    "赛诺医疗",
                    "颅内球囊扩张导管",
                    "获批上市"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "每日医药简讯：多地医用耗材带量采购陆续推进、赛诺医疗二代颅内球囊扩张导管获批上市",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-07-05",
            "original_text": "周末要闻2020年7月5日星期日",
            "features": {
                "keywords": [
                    "周末要闻",
                    "2020年7月5日"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "周末要闻2020年7月5日星期日",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 2,
                "Entity_Density": 1,
                "Market_Scope": 4,
                "Time_Proximity": 2,
                "Headline_Structure": 4,
                "Source_Recency": 1
            }
        },
        {
            "time": "",
            "original_text": "益丰药房：副总裁肖再祥拟减持不超3.15万股 拟减持股份",
            "features": {
                "keywords": [
                    "益丰药房",
                    "副总裁",
                    "肖再祥",
                    "减持",
                    "3.15万股"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "益丰药房：副总裁肖再祥拟减持不超3.15万股 拟减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]